Ulixertinib

CAS No. 869886-67-9

Ulixertinib( BVD-523 | VRT752271 )

Catalog No. M17630 CAS No. 869886-67-9

Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 80 In Stock
25MG 129 In Stock
50MG 177 In Stock
100MG 335 In Stock
200MG 484 In Stock
500MG 771 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ulixertinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.
  • Description
    Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BVD-523 | VRT752271
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ERK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    869886-67-9
  • Formula Weight
    433.33
  • Molecular Formula
    C21H22Cl2N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 45 mg/mL; 103.85 mM
  • SMILES
    [nH]1c(cc(c1)c1cc(ncc1Cl)NC(C)C)C(=O)N[C@H](CO)c1cc(ccc1)Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ward RA, et al. J Med Chem. 2015, 58(11), 4790-4801.
molnova catalog
related products
  • Beclamide

    Beclamide is used as antiepiletics.

  • PRGL493

    PRGL493 is an inhibitor of long-chain acyl-CoA synthetase 4 (ACSL4).1It inhibits formation of arachidonoyl-CoA (AA-CoA) from arachidonic acid in, as well as the proliferation and migration of, PC3 and MDA-MB-231 cancer cells when used at a concentration of 50 μM.

  • LSP-249

    LSP-249 is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell.